Author name: oliviamoss

Novartis provides update on Phase III STAND trial assessing crizanlizumab

Update on Phase III STAND trial assessing crizanlizumab

2 Comments / Pharmaceuticals /

Novartis provides update on Phase III STAND trial assessing crizanlizumab The preliminary results from the ongoing global phase III study STAND indicate no statistically significant difference between crizanlizumab 5mg/kg or crizanlizumab 7.5mg/kg and placebo in annualized rates of vaso-occlusive crises (pain crises) leading to a healthcare visit over the first-year post randomization. These findings are […]

Update on Phase III STAND trial assessing crizanlizumab Read More »

HPE GreenLake, selected to modernize customer experience

HPE GreenLake, selected to modernize customer experience

2 Comments / Cloud /

Hewlett Packard Enterprise has announced that City Electrical Factors (CEF), the United Kingdom’s leading electrical wholesale network, has selected the HPE GreenLake edge-to-cloud platform as the first step in its digital transformation journey. The HPE GreenLake platform will enable CEF to optimize their infrastructure management and improve security using the disaster recovery capabilities of Zerto. Established in 1951,

HPE GreenLake, selected to modernize customer experience Read More »

Bosch to acquire roughly 12 percent shares in Husqvarna in total

Bosch to acquire roughly 12 percent shares in Husqvarna in total

2 Comments / Business /

Bosch agreed to acquire shares in the long-established Swedish company Husqvarna AB. The acquisition will increase its shareholding to roughly 12 percent in the company’s share capital in total. Husqvarna is listed on Nasdaq Stockholm. In acquiring these shares today, Bosch intends to strengthen the battery alliance between the two companies. Husqvarna also includes the

Bosch to acquire roughly 12 percent shares in Husqvarna in total Read More »